1.78
price up icon0.56%   0.01
after-market Handel nachbörslich: 1.77 -0.01 -0.56%
loading

Nls Pharmaceutics Ltd Aktie (NLSP) Neueste Nachrichten

pulisher
Oct 14, 2025

Is NLS Pharmaceutics AG Equity Warrant stock reversal real or fakeEarnings Risk Report & AI Powered Trade Plan Recommendations - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

Will NLS Pharmaceutics AG Equity Warrant stock outperform value stocksQuarterly Growth Report & Community Verified Trade Signals - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

Custom watchlist performance reports with NLS Pharmaceutics AG Equity Warrant2025 Stock Rankings & Reliable Trade Execution Plans - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

Visualizing NLS Pharmaceutics AG stock with heatmaps2025 Price Momentum & Short-Term Swing Trade Alerts - newser.com

Oct 14, 2025
pulisher
Oct 13, 2025

NLS Pharmaceutics AG Stock Analysis and ForecastCandlestick Pattern Analysis & Small Budget Investment Tips - earlytimes.in

Oct 13, 2025
pulisher
Oct 13, 2025

Why NLS Pharmaceutics AG Equity Warrant stock is recommended by analystsJuly 2025 EndofMonth & Real-Time Sentiment Analysis - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Regression analysis insights on NLS Pharmaceutics AG Equity Warrant performanceJuly 2025 Analyst Calls & Daily Stock Trend Watchlist - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Combining machine learning predictions for NLS Pharmaceutics AGJuly 2025 Institutional & Growth Focused Entry Reports - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

What indicators show strength in NLS Pharmaceutics AG Equity WarrantJuly 2025 Sentiment & Stock Portfolio Risk Management - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Can a trend reversal in NLS Pharmaceutics AG lead to recoveryWeekly Stock Analysis & Free Community Supported Trade Ideas - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Is NLS Pharmaceutics AG a candidate for recovery playEarnings Overview Summary & Smart Money Movement Alerts - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Analyzing recovery setups for NLS Pharmaceutics AG Equity Warrant investors2025 Trading Volume Trends & Precise Trade Entry Recommendations - newser.com

Oct 13, 2025
pulisher
Oct 11, 2025

NLS Pharmaceutics files financial statements related to Kadimastem merger By Investing.com - Investing.com Nigeria

Oct 11, 2025
pulisher
Oct 10, 2025

Will NLS Pharmaceutics AG Equity Warrant rebound enough to break evenGold Moves & Real-Time Stock Entry Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

NLS Pharmaceutics files financial statements related to Kadimastem merger - Investing.com India

Oct 10, 2025
pulisher
Oct 10, 2025

NLS Pharmaceutics Announces Strategic Merger with Kadimastem - TipRanks

Oct 10, 2025
pulisher
Oct 10, 2025

Will NLS Pharmaceutics AG Equity Warrant bounce back from current supportQuarterly Trade Report & Real-Time Volume Analysis Alerts - newser.com

Oct 10, 2025
pulisher
Oct 05, 2025

What’s next for NLS Pharmaceutics AG Equity Warrant stock priceQuarterly Earnings Report & Reliable Price Breakout Signals - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

What to expect from NLS Pharmaceutics AG Equity Warrant in the next 30 daysJuly 2025 Rallies & AI Driven Stock Reports - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

How NLS Pharmaceutics AG stock reacts to Fed rate cutsJuly 2025 Closing Moves & Technical Analysis for Trade Confirmation - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Is NLS Pharmaceutics AG stock positioned well for digital economyWeekly Trend Recap & Technical Pattern Based Signals - newser.com

Oct 02, 2025
pulisher
Sep 30, 2025

NLS Pharmaceutics Approve Merger with Kadimastem - citybiz

Sep 30, 2025
pulisher
Sep 30, 2025

NLS Pharmaceutics stock tumbles after merger approval with Kadimastem By Investing.com - Investing.com Nigeria

Sep 30, 2025
pulisher
Sep 30, 2025

NLS Pharmaceutics stock tumbles after merger approval with Kadimastem - Investing.com

Sep 30, 2025
pulisher
Sep 30, 2025

NLSP Stock Faces Highs and Lows: A Closer Look - StocksToTrade

Sep 30, 2025
pulisher
Sep 30, 2025

NLS Pharmaceutics Stock: What’s Next? - timothysykes.com

Sep 30, 2025
pulisher
Sep 30, 2025

NLS Pharmaceutics shareholders approve merger with Kadimastem By Investing.com - Investing.com Australia

Sep 30, 2025
pulisher
Sep 30, 2025

NLS Pharmaceutics Shareholders Approve Merger with Kadimastem - TipRanks

Sep 30, 2025
pulisher
Sep 30, 2025

NLS Pharmaceutics shareholders approve merger with Kadimastem - Investing.com India

Sep 30, 2025
pulisher
Sep 30, 2025

NLS Pharmaceutics shareholders approve merger with Kadimastem and related proposals at extraordinary general meeting - MarketScreener

Sep 30, 2025
pulisher
Sep 30, 2025

84.4% Ownership Stake: Kadimastem-NLS Pharma Merger Creates NewCelX with ALS and Diabetes Pipeline - Stock Titan

Sep 30, 2025
pulisher
Sep 29, 2025

Is NLS Pharmaceutics AG stock dividend yield sustainableWeekly Risk Summary & High Yield Equity Trading Tips - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

NLS Pharmaceutics (NASDAQ:NLSP) Rating Increased to Hold at Wall Street Zen - Defense World

Sep 29, 2025
pulisher
Sep 29, 2025

Visual trend scoring systems applied to NLS Pharmaceutics AG Equity WarrantJuly 2025 Price Swings & Accurate Buy Signal Alerts - newser.com

Sep 29, 2025
pulisher
Sep 22, 2025

Using economic indicators to assess NLS Pharmaceutics AG Equity Warrant potentialWeekly Risk Summary & Scalable Portfolio Growth Methods - newser.com

Sep 22, 2025
pulisher
Sep 22, 2025

Is NLS Pharmaceutics AG stock ready for a breakoutTrade Analysis Summary & Weekly High Return Stock Opportunities - newser.com

Sep 22, 2025
pulisher
Sep 21, 2025

Market reaction to NLS Pharmaceutics AG Equity Warrant’s recent newsJuly 2025 Breakouts & Expert Approved Momentum Trade Ideas - newser.com

Sep 21, 2025
pulisher
Sep 21, 2025

Custom strategy builders for tracking NLS Pharmaceutics AGMarket Performance Report & AI Enhanced Market Trend Forecasts - newser.com

Sep 21, 2025
pulisher
Sep 20, 2025

Rally Mode: Does NLS Pharmaceutics AG stock benefit from AI growthPrice Action & Low Risk Growth Stock Ideas - خودرو بانک

Sep 20, 2025
pulisher
Sep 20, 2025

NLS Pharmaceutics Engages New Accounting Firm After Marcum’s Resignation - The Globe and Mail

Sep 20, 2025
$21.75
price down icon 5.15%
$85.96
price up icon 1.45%
$32.75
price up icon 0.21%
$102.61
price up icon 0.30%
$161.38
price down icon 1.56%
biotechnology ONC
$320.94
price down icon 1.86%
Kapitalisierung:     |  Volumen (24h):